Custom Pharma Services
Andy Smith has over a decade of experience in quality control within the pharmaceutical industry. From April 2021 to May 2024, Andy served as the Laboratory Operations Team Leader and previously as the Finished Products Team Manager at Custom Pharma Services, overseeing teams conducting chemical and physical analyses on solid dosage forms in a GxP MHRA-audited lab. Prior to this, from May 2019 to January 2021, Andy was the Quality Control Chemistry & Components Manager at Allergy Therapeutics, managing analysis for allergy immunotherapy products. Andy gained foundational experience at Nelsons from August 2012 to April 2019, where roles included Quality Control Team Leader, Senior Quality Control Analyst, and Quality Control Analyst, performing a range of analyses in GxP MHRA and FDA-audited environments. Andy holds a Master of Chemistry (MChem) with Honours from the University of Sussex, obtained in June 2012.
This person is not in any teams
This person is not in any offices
Custom Pharma Services
1 followers
Custom Pharma Services is located in Brighton, UK since 1979 and is a full-service contract development and manufacturing organisation (CDMO) providing services tailored to your needs, no matter how niche or complex. Custom covers the full spectrum of activities from development through commercial manufacturing for both clinical and commercial use. Specialising in Oral Solid Dosage forms with the ability to handle highly potent drugs and poorly bioavailable compounds Custom really is your one stop resource. With direct access to highly skilled experts offering a partnership approach Custom Pharma Services truly has a molecule first mentality, managing all projects with the end in mind. Custom Can! • Custom Pharma is a CDMO offering clinical and commercial manufacturing of tablets, capsules, powders (oral-solid-dose) for human use. • Services comprise pre-formulation and formulation development, analytical development, stability testing, clinical trial material manufacturing • Commercial Production • Pre-clinical formulation development and solubilisation • Material characterisation • Drug in capsule approach to accelerate early clinical studies • Specialists in low dosage (sub-mg) formulations • Contained manufacturing for highly potent APIs • Orphan drug development • Formulation development of poorly soluble drugs, including spray drying capabilities